From: BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
 |  | Hazard ratio* | 95% confidence interval | p-value |
---|---|---|---|---|
Age (years) | ≤ 53 vs. > 53 (the median) | 0.56 | 0.22-1.45 | 0.233 |
Tumor size (mm2) | ≤ 736 vs. > 736 (the median) | 0.61 | 0.22-1.71 | 0.349 |
 | not measurable vs. > 736 | 0.55 | 0.18-1.66 | 0.287 |
Karnofsky performance score | ≤ 70 vs. 80 or 90 | 1.24 | 0.50-3.07 | 0.648 |
Surgery | Complete resection vs. biopsy/partial resection | 3.03 | 1.05-8.74 | 0.040 |
Pre-treatment with temozolomide | yes vs. no | 0.81 | 0.31-2.13 | 0.674 |
Previous relapses | 1 vs. more than 1 | 1.81 | 0.51-6.48 | 0.357 |